DESIGN, SYNTHESIS, AND ANTIVIRAL ACTIVITY OF ALPHA-NUCLEOSIDES - D-ISOMER AND L-ISOMER OF LYXOFURANOSYL-BENZIMIDAZOLES AND (5-DEOXYLYXOFURANOSYL)BENZIMIDAZOLES
Mt. Migawa et al., DESIGN, SYNTHESIS, AND ANTIVIRAL ACTIVITY OF ALPHA-NUCLEOSIDES - D-ISOMER AND L-ISOMER OF LYXOFURANOSYL-BENZIMIDAZOLES AND (5-DEOXYLYXOFURANOSYL)BENZIMIDAZOLES, Journal of medicinal chemistry, 41(8), 1998, pp. 1242-1251
Several 2-substituted alpha-D- and alpha-L-lyxofuranosyl and 5-deoxyly
xofuranosyl derivatives of 5,6-dichloro-2-(isopropylamino)-1- -(beta-L
-ribofuranosyl)benzimidazole (1263W94) and ,6-trichloro-1-(beta-D-ribo
furanosyl)benzimidazole (TCRB) were synthesized and evaluated for acti
vity against two herpesviruses (HSV-1 and HCMV) and for their cytotoxi
city against HFF and KB cells. Condensation of 1,2,3,5-tetra-O-acetyl-
L-lyxofuranose (2a) with 2,5,6-trichlorobenzimidazole (1) yielded the
or-nucleoside 3a. The 2-bromo derivative and 2-methylamino derivative
were prepared by treatment of 3a with HBr followed by deprotection or
from methylamine, respectively. Compound 3a was deprotected and the re
sultant nucleoside used to prepare the 2-cyclopropylamino and 2-isopro
pylamino derivatives. The 2-alkylthio nucleosides were prepared by con
densing 2a with 5,6-dichlorobenzimidazole-2-thione followed by deprote
ction. Alkylation of this adduct gave the 2-methylthio and 2-benzylthi
o derivatives. Condensation of 5-deoxy-1,2,3-tri-O-acetyl-L-lyxofurano
syl, prepared from L-lyxose, with 1 or 2-bromo-5,6-dichlorobenzimidazo
le (15), followed by deprotection, gave the 2-chloro or 2-bromo-5'-deo
xylyxofuranosyl derivative, respectively. The cyclopropylamino derivat
ive was prepared from the 2-chloro derivative. All D-isomers were prep
ared in an analogous fashion from D-lyxose. Either compounds were inac
tive against HSV-1 or weak activity was poorly separated from cytoxici
ty. In contrast, the 2-halogen derivatives in both the alpha-lyxose an
d 5-deoxy-alpha-lyxose series were active against the Towne strain of
HCMV. The 5-deoxy alpha-L analogues were the most active, IC50's = 0.2
-0.4 mu M, plaque assay; IC90's = 0.2-2 mu M, yield reduction assay. A
ll of the 2-isopropylamino or 2-cyclopropylamino derivatives were less
active (IC50's = 60-100 mu M, plaque assay; IC90's = 17-100 mu M, yie
ld reduction assay) and were not cytotoxic. The methylamino, thio, and
methylthio derivatives were neither active nor cytotoxic. The benzylt
hio derivatives were weakly active, but this activity was poorly separ
ated from cytotoxicity. The alpha-lyxose L-isomers were more active in
a plaque assay against the AD169 strain of HCMV compared to the Towne
strain, thereby providing additional evidence of antiviral specificit
y.